Bayer Revenue 2010-2024 | BAYRY
Bayer annual/quarterly revenue history and growth rate from 2010 to 2024. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Bayer revenue for the quarter ending September 30, 2024 was $10.961B, a 2.62% decline year-over-year.
- Bayer revenue for the twelve months ending September 30, 2024 was $50.613B, a 0.31% decline year-over-year.
- Bayer annual revenue for 2023 was $51.558B, a 3.56% decline from 2022.
- Bayer annual revenue for 2022 was $53.459B, a 2.5% increase from 2021.
- Bayer annual revenue for 2021 was $52.152B, a 10.28% increase from 2020.
Bayer Annual Revenue
(Millions of US $) |
| 2023 |
$51,558 |
| 2022 |
$53,459 |
| 2021 |
$52,152 |
| 2020 |
$47,291 |
| 2019 |
$48,770 |
| 2018 |
$46,751 |
| 2017 |
$39,577 |
| 2016 |
$51,755 |
| 2015 |
$51,438 |
| 2014 |
$56,148 |
| 2013 |
$53,341 |
| 2012 |
$51,135 |
| 2011 |
$50,876 |
| 2010 |
$46,593 |
| 2009 |
$43,467 |
Bayer Quarterly Revenue
(Millions of US $) |
| 2024-09-30 |
$10,961 |
| 2024-06-30 |
$11,893 |
| 2024-03-31 |
$14,945 |
| 2023-12-31 |
$12,814 |
| 2023-09-30 |
$11,256 |
| 2023-06-30 |
$12,042 |
| 2023-03-31 |
$15,445 |
| 2022-12-31 |
$12,027 |
| 2022-09-30 |
$11,362 |
| 2022-06-30 |
$13,642 |
| 2022-03-31 |
$16,428 |
| 2021-12-31 |
$12,678 |
| 2021-09-30 |
$11,534 |
| 2021-06-30 |
$13,078 |
| 2021-03-31 |
$14,863 |
| 2020-12-31 |
$12,107 |
| 2020-09-30 |
$9,944 |
| 2020-06-30 |
$11,070 |
| 2020-03-31 |
$14,171 |
| 2019-12-31 |
$10,148 |
| 2019-09-30 |
$10,931 |
| 2019-06-30 |
$12,909 |
| 2019-03-31 |
$14,782 |
| 2018-12-31 |
$12,695 |
| 2018-09-30 |
$11,517 |
| 2018-06-30 |
$11,307 |
| 2018-03-31 |
$11,232 |
| 2017-12-31 |
$4,102 |
| 2017-09-30 |
$9,432 |
| 2017-06-30 |
$13,411 |
| 2017-03-31 |
$12,633 |
| 2016-12-31 |
$12,646 |
| 2016-09-30 |
$12,568 |
| 2016-06-30 |
$13,367 |
| 2016-03-31 |
$13,173 |
| 2015-12-31 |
$12,109 |
| 2015-09-30 |
$12,279 |
| 2015-06-30 |
$13,374 |
| 2015-03-31 |
$13,676 |
| 2014-12-31 |
$13,819 |
| 2014-09-30 |
$13,517 |
| 2014-06-30 |
$14,346 |
| 2014-03-31 |
$14,466 |
| 2013-12-31 |
$13,477 |
| 2013-09-30 |
$12,774 |
| 2013-06-30 |
$13,529 |
| 2013-03-31 |
$13,560 |
| 2012-12-31 |
$12,779 |
| 2012-09-30 |
$12,095 |
| 2012-06-30 |
$13,078 |
| 2012-03-31 |
$13,183 |
| 2011-12-31 |
$12,366 |
| 2011-09-30 |
$12,277 |
| 2011-06-30 |
$13,314 |
| 2011-03-31 |
$12,870 |
| 2010-12-31 |
$12,390 |
| 2010-09-30 |
$11,069 |
| 2010-06-30 |
$11,712 |
| 2010-03-31 |
$10,969 |
| 2009-12-31 |
$11,282 |
| 2009-09-30 |
$11,087 |
| 2009-06-30 |
$10,908 |
| 2009-03-31 |
$10,327 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Large Cap Pharmaceutical |
$21.338B |
$51.553B |
|
Bayer AG is a life science company with core competencies in the areas of health care and agriculture. With the company's focus completely on the Life Science businesses, a new organizational structure was introduced effective Jan 1, 2016. Bayer Group now comprise exclusively of the Life Science businesses. The company started reporting in three segments ' Pharmaceuticals, Consumer Health and Crop Science ' from the third quarter of 2019. Both Animal Health and Currenta were reported as discontinued operations in the quarter. The company acquired U.S. seed giant Monsanto in June, 2018. With the acquisition, Bayer now has the strongest portfolio of seed and crop protection products for a wide range of crops and indications, the best research and development platform and the leading digital farming business.
|
